Flaxseed Lignan Complex Administration in Older Human Type 2 Diabetics Manages Central Obesity and Prothrombosis—An Invitation to Further Investigation into Polypharmacy Reduction

Table 1

Patient characteristics upon entry.


Parameter	Value

Age (years)
Waist circumference (cm)	99.3 4.2
BMI (kg/m²)	31.2 2.2
Glucose (mMol/L)	7.1 0.8
A1c (%)	7.2 1.2
HDL-c (mMol/L)	1.1 0.1
LDL-c (mMol/L)	2.5 0.1
Small dense LDL-c (mMol/L)	0.3 0.04
Cholesterol (mMol/L)	4.6 0.3
Triglycerides (mMol/L)	1.7 0.2
BP: systolic (mm Hg)	137.4 5.1
BP: diastolic (mm Hg)	83.3 2.1
CRP (mG/L)	2.6 1.2
IL-6 (pG/mL)	3.7 1.9
TNF- (pG/mL)	1.2 0.2
Bleeding time (seconds)	219.2 11.6
Oxidised LDL (U/L)	56.8 4.6

Values reflect duplicate assays of each blood sample (volumes are for plasma). Values are rounded to the nearest tenth. Data (mean SEM) is for the 16 patients who completed the trial.

Journal of Nutrition and Metabolism

Flaxseed Lignan Complex Administration in Older Human Type 2 Diabetics Manages Central Obesity and Prothrombosis—An Invitation to Further Investigation into Polypharmacy Reduction

Table 1